MeSH tree: E04.062
For decades, people have been told that their weight problems can be solved by math: Calories in, calories out. If weight were a simple math equation, more people would likely have the weight they desire. But it is much more ...
May 25, 2026
0
6
Substantial and sustained weight loss has been linked to a reduced risk of cancer and cancer-related death, mainly in women. Two new studies now provide clues to why the risk is reduced—and suggest that gender, metabolism ...
May 25, 2026
0
5
Metabolic/bariatric surgery is a highly effective treatment for people living with severe obesity and/or metabolic health conditions, which works through changing the anatomy of the digestive system and thereby changing the ...
May 22, 2026
0
6
For a very long time, bariatric surgery, in which doctors removed a portion of the stomach, was the standard procedure for helping patients lose weight and manage obesity, alongside metabolic disorders such as diabetes, high ...
For many women with lipedema, the diagnosis comes after years of being told the same thing: eat less, not more. The problem is that the fat accumulating around their hips and legs isn't responding to diet or exercise, because ...
May 19, 2026
0
3
A new systematic review and meta-analysis of studies presented at the European Congress on Obesity in Istanbul, Turkey (May 12–15) shows that diet and exercise interventions result in a lower proportion of fat-free mass loss ...
May 14, 2026
0
5
Changes in gut microbiota after bariatric surgery are strongly linked to altered metabolic health and sustained improvement in type 2 diabetes, according to a study led by researchers at the University of Gothenburg.
May 7, 2026
0
4
Metabolic and bariatric surgery offers significantly greater long-term protection against heart attack, stroke and death than widely used GLP-1 drugs in older adults with obesity and diabetes, according to a new real-world ...
May 6, 2026
0
6
Metabolic and bariatric surgery delivers significantly greater weight loss and higher rates of obesity-related disease remission than glucagon-like peptide-1 receptor agonists (GLP-1s), according to one of the largest and ...
May 6, 2026
0
6
A new real-world analysis of more than 90,000 patients with obesity and type 2 diabetes finds metabolic and bariatric surgery costs significantly less than weekly injections of GLP-1 drugs over a two-year period, according ...
May 5, 2026
0
5
